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Central obesity and renal abnormalities 





Obesity with a central body fat distribution, is related to essential hypertension 
and diabetes. Since the latter are related to renal damage, it follows that obesity 
may also be involved in renal damage. Whether this dependents on fat distribution 
independently of hypertension and diabetes has not been elucidated yet. We hy-
pothesize that fat distribution is more important for renal abnormalities than obe-
sity per se in non-diabetic subjects. 
We studied cross-sectionally the relation between obesity and microalbuminu-
ria, elevated and diminished filtration, in 7676 non-diabetic subjects of the 
PREVEND population. Microalbuminuria was defined as a urinary albumin excre-
tion of 30-300 mg/24hr. Creatinine clearance was measured as the mean of two 
24h creatinine clearances and corrected for body surface area. Elevated and dimin-
ished filtration were defined as a filtration ± 2X SD of a non-diabetic, lean control 
group with a peripheral fat distribution and a urinary albumin excretion of 0-15 
mg/24h, corrected for age and sex. The total population was divided into four 
groups according to obesity (body mass index > 27 kg/m2) and fat distribution 
(central: waist hip ratio  0.9 for males and  0.8 for females)  
All subjects with a central fat distribution had higher blood pressure, 
cholesterol, glucose, and albumin excretion and lower creatinine clearance than 
subjects with a peripheral fat distribution. In a logistic regression analysis we 
adjusted for age, gender, blood pressure, antihypertensive- and lipid-lowering 
medication, cholesterol and glucose levels, and smoking. Obese subjects with a 
central fat distribution showed an independent higher risk for microalbuminuria 
(relative risk 1.5 [95% CI 1.13-1.98]), elevated (1.7 [1.13-2.58]), and diminished 
filtration (2.1 [1.28-3.41]) as compared to lean subjects with a peripheral fat 
distribution. Interestingly, lean subjects with a central fat distribution also showed 
an independent higher risk for diminished filtration (2.0 [1.33-3.10]). Finally by 
dividing waist hip ratio in quartiles, it followed that the higher the waist hip ratio 
the higher the risk for diminished filtration.  
In conclusion, not only obese, but also lean subjects with a central fat distribu-
tion  are at risk for microalbuminuria and renal function impairment, independent of 
blood pressure and plasma glucose. Therefore, a central pattern of fat distribution 
seems to be more important than obesity per se. 
 

Central obesity and renal abnormalities 
48                               Risk factors for renal abnormalities 
Introduction 
 
The incidence of obesity, de-
fined1 as a body mass index of 
more than 27 kg/m2, appears to be 
steadily increasing2. Since exces-
sive weight gain initiates a cas-
cade of metabolic, endocrine, 
cardiovascular, and renal changes, 
obesity is a major health problem.  
The impact of obesity on renal 
function has been investigated 
over the years. Obesity is associ-
ated with both renal hyperfiltra-
tion3-5 or hyperperfusion6 and with 
microalbuminuria7. Moreover, 
experimental observations of an 
increased glomerular filtration 
rate (GFR), mainly in superficial 
nephrons and in association with 
an expansion of glomerular area 
and mesangial matrix, were made 
in Zucker rats with genetic obe-
sity8. Later on GFR tends to nor-
malize and subsequently de-
creases together with the devel-
opment of progressive albuminu-
ria and glomerulosclerosis9,10, 
suggesting that also in obesity 
hyperfiltration might precede 
renal function loss. Hyperfiltra-
tion is also a frequent early find-
ing in patients with diabetes11 and 
a possible predictor of the subse-
quent development of microalbu-
minuria and ultimate diabetic 
nephropathy12. Also from human 
studies it has been argued that 
obesity may lead to end-stage 
renal disease. For instance, focal 
glomerular sclerosis and/or dia-
betic nephropathy have been ob-
served in massive obese patients 
who presented with proteinuria13. 
Recently, Praga et al.14 showed 
that obese subjects were more at 
risk to develop proteinuria and 
renal failure after unilateral 
nephrectomy than non-obese sub-
jects. 
There is evidence however, 
that not obesity per se, but the 
distribution of body fat is related 
to a variety of physiological aber-
rations. Indeed, a central body fat 
distribution is related to hyperin-
sulinemia, hypertension, hyperlip-
idemia, and atherosclerosis15,16. 
Interestingly, Scaglione et al.17 
also showed in a small study, that 
subjects with a central fat 
distribution had a reduced renal 
plasma and blood flow and an 
increased filtration fraction and 
albuminuria, whereas this could 
not be observed in subjects with a 
peripheral fat distribution. On the 
other hand, these were both nor-
motensive and hypertensive sub-
jects and no comparison was 
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made with lean subjects with a 
central fat distribution. 
We therefore hypothesized, 
that a central fat distribution, also 
in non-obese subjects, is related to 
renal function abnormalities, 
characterized as microalbuminu-
ria, elevated or diminished filtra-
tion in a non-diabetic population. 
To test this hypothesis, we studied 
the cross-sectional relation be-
tween obesity, body fat distribu-
tion, albuminuria, and creatinine 
clearance in a large cohort, col-
lected to study the causes and 
consequences of microalbuminu-






This study is part of the ongo-
ing ‘PREVEND’ study  (Preven-
tion of REnal and Vascular ENd 
stage Disease), in the city of 
Groningen, the Netherlands. All 
inhabitants, aged 28-75 years 
(n=85,421), were asked to send in 
a morning urine sample and to fill 
out a short questionnaire on 
demographics and cardiovascular 
history. 40,856 subjects (47.8%) 
responded. Our actual study co-
hort was drawn from this cohort 
based on all subjects with a uri-
nary albumin concentration of 
 10mg/l (n=7,768) in their morn-
ing urine sample and a randomly 
selected control group with a uri-
nary albumin concentration of 
<10 mg/l (n=3,395).  Details of 
this protocol have been described 
elsewhere18. In total 11.163 sub-
jects were invited to the outpatient 
clinic, of which 8.592 subjects 
completed the screening program. 
Subjects using insulin or pregnant 
women were excluded from par-
ticipation in this screening pro-
gram. Our total population con-
sisted mainly of Caucasian sub-
jects. Only 68 (0.9 %) subjects 
were Black and 163 (2.1 %) sub-
jects were Asian. These groups 
were too small for a separate 
analysis. The study was approved 
by the medical ethics committee 
and conducted in accordance with 
the guidelines of the declaration 
of Helsinki. All participants at-
tending the outpatient clinic gave 
written informed consent.  
 
Study design 
The screening program in the 
outpatient clinic consisted of two 
visits. At the first visit, partici-
pants completed a self-
administered questionnaire re-
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garding demographics, cardiovas-
cular and renal history, and drug 
use. After removal of shoes and 
heavy clothing, weight was meas-
ured to the nearest 0.5 kg with a 
Seca balance scale (seca Vogel & 
Halke GmbH & Co., Hamburg, 
Germany). Height was measured 
to the nearest 0.5 cm. Minimal 
waist circumference was meas-
ured on bare skin at the natural 
indentation between the 10th rib 
and the iliac crest. Hip circumfer-
ence was measured at the maxi-
mum circumference of the but-
tocks19. At both visits, blood pres-
sure was measured in supine posi-
tion, every minute, for 10 and 8 
minutes (respectively), with an 
automatic Dinamap XL Model 
9300 series monitor (Critikon, 
Tampa, Florida). Subjects were 
asked to collect 24hr urine on two 
consecutive days in the last week 
before the second visit. The sub-
jects were given oral and written 
instructions on how to collect 
24hr urine and they were in-
structed to postpone urine collec-
tion in case of fever, urinary tract 
infection or menstruation and to 
refrain as far as possible from 
heavy exercise during the collec-
tion period. Furthermore, the sub-
jects were asked to store the urine 
cold (4°C) for maximum 4 days 
prior to the second visit. Meas-
urements of urinary volume and 
albumin and creatinine concentra-
tions were performed on each 
collection. At the second visit, 
blood was drawn after an over-
night fast, for determination of 
plasma glucose, and serum 
creatinine and cholesterol. 
 
Calculations 
Systolic and diastolic blood 
pressure was calculated as the 
mean of the last two measure-
ments of the two visits. Body 
mass index was calculated as the 
ratio between weight (kg) and the 
square of height (m) 
(weight/height2). Waist hip ratio 
was calculated as the ratio be-
tween minimal waist circumfer-
ence (cm) and hip circumference 
(cm). Body surface area was cal-
culated according to DuBois-
DuBois20. Creatinine clearance 
was defined as the mean of the 
two creatinine clearances based 
on 24hr urinary creatinine excre-
tions divided by plasma creatinine 
and corrected for body surface 
area (ml.min-1 1.73m-2). Urinary 
albumin excretion is given as the 





Table 1. Population characteristics according to obesity 
 Lean Obese 
 Peripheral  Central  Peripheral  Central  
n % 2457 (32.4) 2513 (33.1) 333 (4.4) 2284 (30.1) 
Male sex % 44.5 54.4* 36.0*† 57.9*†‡ 
Age (yr) 43±11 50±12* 46±12*† 53±12*†‡ 
BMI 22.8±2.1 24.3±1.9* 29.6±2.9*† 30.5±3.4*†‡ 
MWC 0.8±0.1 0.9±0.1* 0.8±0.1† 1.0±0.1*†‡ 
SBP 120±16 128±19* 129±18* 138±20*†‡ 
DBP 70±9 74±9* 73±10* 78±9*†‡ 
HT 12.4 27.6* 28.9* 51.0*†‡ 
Chol. 5.3±1.1  5.7±1.1* 5.7±1.2* 5.9±1.1*†‡ 
Hchol. 13.3 27.9* 21.6*† 33.4*†‡ 
Glucose 4.5±0.6 4.7±0.6* 4.7±0.6* 5.0±0.7*†‡ 
Smoking % 51.8 59.4* 39.8*† 51.2†‡ 
     
UAE 8.0 (5.9-12.5) 8.7 (6.0-15.4)* 8.2 (5.9-12.5)  11.7 (7.2-25.5)*†‡ 
MA  6.7 10.9* 8.1 19.4*†‡ 
HNA 11.2 13.8* 12.3 18.5*†‡ 
Scr. 81±16 84±16* 82±14  87±16*†‡ 
Ccl. 95.1±19.0 91.5±20.8* 93.0±23.3 92.2±22.1* 
EF  3.2 3.7 4.8 5.4*† 
DF  2.7 3.5 3.3 3.5 
 
BMI = Body mass index (kg/m2), MWC = Minimal waist circumference (cm), SBP 
= Systolic blood pressure (mmHg), DBP = Diastolic blood pressure (mmHg), HT 
= hypertension (%), Chol. = cholesterol (mmol/l), Hchol. = hypercholesterolemia 
(%), Glucose (mmol/l), UAE = Urinary albumin excretion (mg/24hr), MA = mi-
croalbuminuria (%), HNA = high normal albuminuria (%), Scr. = Serum creatin-
ine (µmol/l), Ccl = Creatinine clearance (ml/min/1.73m2), EF = elevated filtration 
(%), DF = diminished filtration (%).The mean ± standard deviation is given, ex-
cept for urinary albumin excretion, which is expressed as median with the 25th and 
75th percentiles. *p<0.01 versus lean control subjects with a peripheral fat distri-
bution; †p<0.05 versus lean subjects with a central fat distribution; ‡p<0.01 versus 

































































Central obesity and renal abnormalities 
52                               Risk factors for renal abnormalities 
Laboratory Methods 
Urinary albumin concentration 
was determined by Nephelometry 
with a threshold of 2.3 mg/l and 
intra- and inter-assay coefficients 
of variation of  4.3% and 
 4.4%, respectively (Dade 
Behring Diagnostic, Marburg, 
Germany). Plasma glucose, serum 
cholesterol, and serum and uri-
nary creatinine were determined 
by Kodak Ektachem dry chemis-
try (Eastman Kodak, Rochester, 
New York, United States). Uri-
nary leukocyte and erythrocyte 
measurements were done by 
Nephur-test+leuco sticks (Boe-
hringer Mannheim, Mannheim, 
Germany).  
 
Data handling and definitions  
In the present analysis we ex-
cluded 433 subjects because of 
erythrocyturia or leucocyturia 
(erythrocytes > 50 cells/mm3 or 
leucocytes > 75 cells/mm3, or 
leucocytes = 75 cells/mm3 and 
erythrocytes > 5 cells/mm3). In 
addition, 301 subjects were ex-
cluded because they had non-
insulin dependent diabetes. Diabe-
tes was defined as fasting plasma 
glucose levels  7.0 mmol/l, or 
non-fasting plasma glucose levels 
 11.1 mmol/l or the use of oral 
antidiabetic drugs. Finally, 182 
subjects were excluded because of 
missing data. All together 7676 
subjects were eligible for this 
analysis.  
We differentiated subjects with 
central or peripheral fat distribu-
tion using the ratio of waist to hip 
circumference. Central fat distri-
bution was defined as a waist hip 
ratio  0.9 for males and  0.8 for 
females and peripheral fat distri-
bution was defined as a waist hip 
ratio < 0.9 for males and < 0.8 for 
females21. Obesity was defined1 as 
a body mass index of > 27 kg/m2 
and lean was defined as a body 
mass index of  27 kg/m2. We 
divided our study population in 4 
groups according to body mass 
index (BMI) and waist hip ratio 
(WHR). 1. lean subjects with a 
peripheral fat distribution; 2. lean 
subjects with a central fat 
distribution; 3. obese subjects 
with a peripheral fat distribution; 
4. obese subjects with a central fat 
distribution.  
Furthermore, microalbuminu-
ria was defined according to the 
classic definition, of 30-300 
mg/24hr. Since it has been sug-
gested that the cardiovascular and 
renal risk associated with albu-
minuria may already start at an 
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even lower cut-off point than 
nowadays considered pathologi-
cal22,23, we also defined a group 
with a high normal urinary albu-
min excretion (15-30 mg/24hr). 
elevated or diminished filtra-
tion was defined as a creatinine 
clearance exceeding or below 
more than two times the standard 
deviation of the mean creatinine 
clearance of a group of non-
























subjects with a urinary albumin 
excretion of 0-15 mg/24hr18. The 
mean creatinine clearance with 
the two times standard deviation 
borders was obtained by means of 
a linear regression analysis ad-
justed for age and gender. Hyper-
cholesterolemia was defined as a 
plasma cholesterol of >6.5 or >5.0 
in case of a previous myocardial 
infarction. Hypertension was de-

























Table 2. Relative risks for high normal albuminuria and microalbuminuria ac-
cording to obesity 
 High normal albuminuria 
 crude  age/gender 
Lean peripheral 1.0‡ 1.0‡ 
Lean central 1.4 (1.15-1.61)‡ 1.1 (0.92-1.32) 
Obese peripheral 1.1 (0.80-1.63) 1.1 (0.76-1.55) 
Obese central 2.3 (1.93-2.70)‡ 1.7 (1.45-2.07)‡ 
  
 Microalbuminuria  
 crude age/gender 
Lean peripheral 1.0‡ 1.0‡ 
Lean central 1.8 (1.47-2.21) ‡ 1.2 (0.97-1.48) 
Obese peripheral 1.3 (0.82-1.93) 1.1 (0.71-1.69) 
Obese central 4.0 (3.29-4.83)‡ 2.4 (1.94-2.92)‡ 
 
Relative risk and 95% confidence interval are for the respective lean subjects 
with a central fat distribution, obese subjects with a peripheral fat distribution, 
and obese subjects with a central fat distribution as compared to lean control 
subjects with a peripheral fat distribution. ‡p<0.001. The significance given in 
the group with lean control subjects with a peripheral fat distribution refers to 
the overall significance of the model, with the symbols representing the signifi-
cance as stated before. 
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sure  160 mmHg or a diastolic 
blood pressure of  90 mmHg or 
the use of antihypertensive medi-
cation. Smokers were defined as 
currently smoking and non-
smokers as never have smoked.  
 
Statistical analysis 
All calculations were per-
formed with SPSS version 9.0 
(SPSS, Chicago) software. Con-
tinuous data are reported as mean  
± standard deviation. In case of 
skewed distribution the median 
with 25th and 75th percentile was 
presented. Differences among the 
4 groups were assessed by Chi-
square analysis or ANOVA. All 
p-values are two-tailed. A p-value 
of <0.05 was considered statisti-
cally significant.  
The linear regression model 
used to define elevated and dimin-
ished filtration, was done in the 
following way. First we selected, 
out of the total population, two 
control or ‘normal’ subgroups, 
which consisted of either male or 
female non-diabetic lean control 
subjects with a peripheral fat dis-
tribution and a urinary albumin 
excretion of 0-15 mg/24hr. In a 
linear regression model with 
creatinine clearance corrected for 
body surface area as the depend-
ent variable and age as the inde-
pendent variable we constructed 
the ‘mean’ creatinine clearance 
for men and women separately. 
Since, each of these two sub-
groups showed a normal distribu-
tion concerning creatinine clear-
ance corrected for body surface 
area we used the 2x standard de-
viation borders of this ‘mean’ 
creatinine clearance to define 
elevated and diminished filtra-
tion24. 
To investigate the risk between 
central or peripheral obesity and 
high normal albuminuria, micro-
albuminuria, elevated, or dimin-
ished filtration clearance, we used 
a logistic regression analysis. 
First, crude and age and gender 
adjusted odds ratios were calcu-
lated. Second, to test the inde-
pendent relation between central 
or peripheral obesity and high 
normal albuminuria, microalbu-
minuria, elevated, or diminished 
filtration odds ratios were esti-
mated after adjustment for possi-
ble confounding factors, such as 
age, gender, smoking, systolic and 
diastolic blood pressure, the use 
of antihypertensive medication, 
serum cholesterol, lipid lowering 
medication, and plasma glucose. 


























95% confidence intervals are ex-
pressed as an approximation of 





Table 1 shows the population 
characteristics according to obe-
sity. Both obese, as well as the 
lean subjects with a central fat 
























her blood pressure, glucose, and 
cholesterol levels, and a higher 
percentage of hypertension or 
hypercholesterolemia as com-
pared to the lean control subjects 
with a peripheral fat distribution. 
The obese subjects with a central 
fat distribution were more often of 
male gender, were older, had 
higher blood pressure, glucose, 
and cholesterol levels, and a 
higher percentages of subjects 
 
Table 3. Relative risks for elevated and diminished filtration according to obesity 
 elevated filtration 
 crude  age/gender 
Lean peripheral 1.0‡ 1.0‡ 
Lean central 1.2 (0.86-1.59) 1.4 (0.99-1.87) 
Obese peripheral 1.6 (0.90-2.72) 1.7 (0.95-2.88) 
Obese central 1.8 (1.33-2.37)‡ 2.2 (1.62-3.02)‡ 
  
 diminished filtration 
 crude age/gender 
Lean peripheral 1.0 1.0 
Lean central 1.3 (0.97-1.86) 1.4 (1.00-1.96) 
Obese peripheral 1.3 (0.67-2.44) 1.3 (0.69-2.53) 
Obese central 1.4 (0.98-1.91) 1.5 (1.02-2.07)* 
 
Relative risk and 95% confidence interval are for the respective lean subjects 
with a central fat distribution, obese subjects with a peripheral fat distribution, 
and obese subjects with a central fat distribution as compared to lean control 
subjects with a peripheral fat distribution. *p<0.05, ‡p<0.001. The significance 
given in the group with lean control subjects with a peripheral fat distribution 
refers to the overall significance of the model, with the symbols representing the 
significance as stated before. 
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with hypertension, or hypercho-
lesterolemia as compared to the 
other three groups. 
Concerning the renal parame-
ters, the obese subjects with a 
central fat distribution had a 
higher percentage of high normal 
albuminuria or microalbuminuria 
and a higher serum creatinine as 
compared to the other three 
groups. Moreover, creatinine 
clearance, in the obese group with 
a central fat distribution was 
lower as compared to the creatin-
ine clearances in both the groups 
with a peripheral fat distribution, 
whereas it was similar to the lean 
group with a central fat distribu-
tion. Furthermore, the obese 
group with a central fat 
distribution had a higher percent-
age of subjects with elevated fil-
tration as compared to both lean 
groups. Notably, the lean subjects 
with a central fat distribution also 
had a higher percentage of high 
normal albuminuria and microal-
buminuria, and a higher serum 
creatinine and a lower creatinine 
clearance as compared to the lean 
control subjects with a peripheral 
fat distribution.  
Since the mean value of creat-
inine clearance is only the sum of 
normal and abnormal values, this 
ues, this does not offer optimal 
information about the relationship 
between obesity and creatinine 
clearance. Therefore, we also 
analyzed our data in a logistic 
regression model, with high nor-
mal albuminuria, microalbuminu-
ria, elevated, or diminished filtra-
tion as dependent variables.  
First, we analyzed the crude 
and age and gender adjusted rela-
tion between obesity and albu-
minuria or renal function. Only 
obese subjects with a central fat 
distribution had a higher risk for 
high normal albuminuria, micro-
albuminuria, elevated, and dimin-
ished filtration as compared to 
lean control subjects with a pe-
ripheral fat distribution (Table 2 
and 3).  
Second to assess the independ-
ent relation between obesity and 
renal abnormalities, we adjusted 
for systolic and diastolic blood 
pressure, antihypertensive medi-
cation, serum cholesterol, lipid 
lowering medication, glucose, and 
smoking. Again obese subjects 
with a central fat distribution 
showed an independent higher 
risk for microalbuminuria, ele-
vated, and diminished filtration as 
compared to lean control subjects 




























(table 4). No significant higher 
risk could be observed for high 
normal albuminuria. Notably, lean 
subjects with a central fat 
distribution also showed an 
independent higher risk for a 
diminished filtration. Obese 
subjects with a peripheral fat 
distribution showed no higher risk 


























ables at all (table 4). We also ana-
lyzed our data without correcting 
creatinine clearance for body sur-
face area, which gave similar 
results (data not shown). 
Since from these results a cen-
tral fat distribution seems more 
important than obesity per se, we 
were interested whether there was 
a linear relation between waist hip 
 
Table 4. Adjusted relative risks for high normal albuminuria, microalbuminuria, 
elevated and diminished filtration according to obesity 
 high normal albuminuria microalbuminuria 
Lean peripheral 1.0 1.0† 
Lean central 0.9 (0.73-1.15) 0.8 (0.61-1.07) 
Obese peripheral 1.1 (0.70-1.72) 1.0 (0.56-1.72) 
Obese central 1.2 (0.95-1.56) 1.5 (1.13-1.98)‡ 
   
 elevated filtration  diminished filtration 
Lean peripheral 1.0* 1.0‡ 
Lean central 1.1 (0.76-1.63) 2.0 (1.33-3.10)‡ 
Obese peripheral 1.9 (0.99-3.62) 1.5 (0.63-3.70) 
Obese central 1.7 (1.13-2.58)* 2.1 (1.28-3.41)‡ 
 
Adjusted for the confounders: systolic and diastolic blood pressure, antihyper-
tensive medication, serum cholesterol, lipid lowering medication, plasma glu-
cose, and smoking. Relative risk and 95% confidence interval are for the re-
spective lean subjects with a central fat distribution, obese subjects with a pe-
ripheral fat distribution, and obese subjects with a central fat distribution as 
compared to lean control subjects with a peripheral fat distribution. *p<0.05, 
‡p<0.01, †p<0.001. The significance given in the group with lean control sub-
jects with a peripheral fat distribution refers to the overall significance of the 
adjusted model, with the symbols representing the significance as stated before. 
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Figure 1. 
Relative risk, and 95% confidence
intervals, for a diminished filtration
among quartiles of waist hip ratio.
p<0.01 for the overall model. 
ratio and a diminished filtration. 
Therefore, we analyzed our data 
in a logistic regression analysis 
with a diminished filtration as the 
dependent variable and waist hip 
ratio in quartiles. Figure 1 shows 
that there indeed was a linear 
relation between waist hip ratio 
and a diminished filtration, even 
when adjusted for confounders 
such as age, gender, systolic and 
diastolic blood pressure, anti-
hypertensive medication, serum 
cholesterol, lipid lowering medi-
cation, glucose, and smoking 





This study shows that nondia-
betic obese subjects with a central 
fat distribution have a higher risk 
for microalbuminuria, elevated 
and diminished filtration, whereas 
obese subjects with a peripheral 
fat distribution only have a 
slightly, not significant, higher 
risk for elevated filtration. Inter-
estingly, not only obese subjects, 
but also lean subjects with a cen-
tral fat distribution had a higher 
risk for diminished filtration. 
It seems from our data, that fat 























than obesity per se for renal ab-
normalities, since also the lean 
subjects with a central fat 
distribution showed a higher risk 
for a diminished filtration. 
Furthermore, the relation between 
fat distribution, measured as waist 
hip ratio, and the risk for dimin-
ished filtration appeared linear.  
What could be the underlying 
mechanism making subjects with 
a central fat distribution more 
prone for impaired renal function? 
Waist hip ratio
















There is strong evidence that a 
central body fat distribution is 
related to insulin resistance15,25. 
Furthermore, higher insulin and 
glucagon levels were found in 
patients with a central fat distribu-
tion as compared to patients with 
a peripheral fat distribution26. It 
has been suggested that both insu-
lin and glucagon by means of its 
effects on renal hemodynamics 
may influence glomerular filtra-
tion rate and albuminuria27-29. 
Since we did not measure insulin 
levels, we are not entitled to make 
a statement about insulin resis-
tance in our obese subjects with a 
central fat distribution. On the 
other hand, clustering of features 
of the metabolic syndrome such 
as hypertension, high plasma glu-
cose, hypercholesterolemia, and a 
higher urinary albumin excretion 
could be observed particularly in 
our obese subjects with a central 
fat distribution.  
The question is whether this 
impaired renal function, in central 
obesity, is due to the accompany-
ing hypertension and diabetes, 
which are so frequently present in 
obese subjects. No clinical studies 
so far have tried to establish an 
independent relation between 
obesity and renal function. Our 
study renders us the opportunity 
to investigate the independent 
relation between central obesity 
and renal abnormalities, since it is 
a large population based study 
and therefore suitable for correct-
ing for confounders such as hy-
pertension and diabetes. We 
choose to correct for diabetes by 
selecting a nondiabetic popula-
tion. On the other hand, since 
diabetes is a continuum and there 
exists a state of pre-diabetes 
which is often associated with 
central obesity, we also corrected 
for plasma glucose. Interestingly, 
our study indeed showed an inde-
pendent effect of obesity on renal 
abnormalities. Also by changing 
our model, by omitting one of the 
variables, the results remained 
similar.  
As to albuminuria, we also ob-
served that obese subject with a 
central fat distribution had a 
higher risk for microalbuminuria, 
which is in accordance with the 
literature26,30. Since microalbu-
minuria is strongly related to hy-
pertension or high blood pressure, 
and since obese subjects with a 
central fat distribution have higher 
blood pressures, it was remark-
able that the relation between 
central obesity and microalbu-
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minuria was independent of blood 
pressure. Interestingly, no in-
creased urinary albumin excretion 
could be observed in obese sub-
jects with a peripheral fat distribu-
tion, even without correcting for 
their higher blood pressure. Mi-
croalbuminuria might be viewed 
of as a marker to identify subjects 
at risk to develop renal function 
loss. We recently showed that this 
does not only hold true for diabe-
tes, but that a similar pattern be-
tween albuminuria and renal func-
tion can be found in a non-
diabetic population18. 
We corrected creatinine clear-
ance for body surface area, since 
the impact of body composition 
on renal function is known. It has 
been suggested that correcting for 
body surface area might give in-
appropriate low values of renal 
plasma flow when calculated for 
obese subjects17. We therefore 
also analyzed our data without 
correcting for body surface area, 
which gave similar results.  
Obese subjects showed a 
higher point estimate for elevated 
filtration which was not signifi-
cant. This indicates, that obese 
subjects with a peripheral fat dis-
tribution might have a higher risk 
for elevated filtration. Since they 
do not show a higher risk for a 
diminished filtration, this might 
indicate that in these subjects 
elevated filtration is due to a high 
cardiac output state with increased 
total blood volume.  
Caution should be applied 
when interpreting our data, since 
this is only a cross-sectional 
study. Hopefully it arouses other 
researchers to reconsider their 
view on obesity induced renal 
disease. Cross-sectional studies 
render us the opportunity to inves-
tigate more risky hypothesis, 
without the effort and the costs 
which comes with follow-up stud-
ies. At present, these subjects are 
followed for changes in renal 
function. Such data will be needed 
to confirm our present observa-
tion. 
In conclusion, subjects with a 
central fat distribution are at risk 
for renal abnormalities independ-
ent of blood pressure and plasma 
glucose. This might indicate that 
fat distribution, apart from hyper-
tension and diabetes, is more im-
portant for renal abnormalities 
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